We focus exclusively on the pharmaceutical and healthcare sectors across the Middle East and Africa, providing intelligence, regulatory guidance, and market access expertise for biopharma, generics, biosimilars, and cell & gene therapy companies.

Our coverage includes Saudi Arabia, the United Arab Emirates, Kuwait, Qatar, Bahrain, Oman, Egypt, and key African markets, with particular expertise in the GCC region’s evolving healthcare landscape.

We help global pharma and biotech firms navigate regulatory frameworks, assess market opportunities, and build commercial strategies tailored to each country’s environment, ensuring faster and more predictable market access.

Our team combines hands-on local experience, strategic insight, and an established network across ministries, payers, and regulators — enabling practical solutions that translate vision into measurable results.

Simply fill out the consultation form or reach us directly at